| 000 | 01771 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513072445.0 | ||
| 264 | 0 | _c19930803 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19930715)72:2<583::aid-cncr2820720241>3.0.co;2-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNavari, R M | |
| 245 | 0 | 0 |
_aComparison of intermittent ondansetron versus continuous infusion metoclopramide used with standard combination antiemetics in control of acute nausea induced by cisplatin chemotherapy. _h[electronic resource] |
| 260 |
_bCancer _cJul 1993 |
||
| 300 |
_a583-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiemetics _xadministration & dosage |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 | _aCosts and Cost Analysis |
| 650 | 0 | 4 |
_aDexamethasone _xadministration & dosage |
| 650 | 0 | 4 |
_aDiphenhydramine _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLorazepam _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetoclopramide _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNausea _xchemically induced |
| 650 | 0 | 4 |
_aOndansetron _xadministration & dosage |
| 700 | 1 | _aProvince, W S | |
| 700 | 1 | _aPerrine, G M | |
| 700 | 1 | _aKilgore, J R | |
| 773 | 0 |
_tCancer _gvol. 72 _gno. 2 _gp. 583-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19930715)72:2<583::aid-cncr2820720241>3.0.co;2-9 _zAvailable from publisher's website |
| 999 |
_c8318470 _d8318470 |
||